While further research is needed, our findings suggest that it may be beneficial to use erlotinib, a relatively non-toxic targeted agent, to initially treat patients with advanced lung cancer, rather than use conventional chemotherapy regimens.
-Bruce Johnson
Select a background
More quotes by Bruce Johnson
Popular Authors
A curated listing of popular authors.